Repurposing psychopharmacology: A two-way street?

Young, Allan H

Young, Allan H.

Young AH; Department of Psychological Medicine, Academic Psychiatry, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK.

J Psychopharmacol ; 35(12): 1439-1440, 2021 12.

Article in English | MEDLINE | ID: covidwho-1575977

Subject(s)

COVID-19 Drug Treatment; Depressive Disorder/drug therapy; Drug Repositioning; Fluvoxamine/therapeutic use; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Neurotransmitter Agents/pharmacology; Animals; Humans; Neurotransmitter Agents/adverse effects; Psychopharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / Neurotransmitter Agents / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Depressive Disorder / Drug Repositioning / COVID-19 Drug Treatment Limits: Animals / Humans Language: English Journal: J Psychopharmacol Journal subject: Psychopharmacology Year: 2021 Document Type: Article Affiliation country: 02698811211064648

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google